The numbers of infected people revealed today remain stable compared to Wednesday (23,904) and when a similar number of tests was carried out, 356,085 compared to 351,221 calculated on Wednesday.
The total number of deaths in Italy amounts to 109,847 since the start of the health emergency in February 2020, with a total of 3,607,083 infections detected.
Hospital pressure remains stable, with 32,630 people hospitalized among the current 563,479 positive cases, 260 less than on Wednesday. Among them, 3,681 remain in intensive care (minus 29).
Italy has administered 10,324,127 vaccines to date, while 3,237,582 people have already received their necessary doses.
The vaccination plan continues on a day when Alessio D’Amato, Health advisor for the region of Lazio, whose capital is Rome, assured in a message to the Government that the region will stop immunizing its population against covid-19 if the vaccines foreseen not be delivered within the next 24 hours.
On Wednesday, the Italian Government approved a new decree that keeps the entire country in a “red” (maximum restrictions) or “orange” (intermediate level) zone until April 30, which include a ban on travel between regions , and with bars and restaurants providing only meals at home.
Currently, ten Italian regions remain in the “red zone”, while the rest of the territory is in the “orange” zone. However, and from Saturday until April 5, the three days of Holy Week, the entire country will remain subject to the “red” zone of the highest restrictions.
At the same time, it was revealed today that Italy received several million fewer doses of anti-covid-19 vaccine in the course of the first quarter of 2021, compared to its March predictions and which already included delivery failures announced in the meantime.
According to a document dated March 3, the Government expected to receive 15.69 million doses in the first quarter, but the figures from the Ministry of Health and updated today indicate 11.25 million doses delivered in the Italian peninsula.
Delays in the delivery of the AstraZeneca vaccine are pointed out as the main cause for non-compliance with the market agreement envisaged by the Government.
Get the latest news delivered to your inbox
Follow us on social media networks